Schedule 13D ownership disclosure
Lucid Diagnostics Inc
Common Stock, par value $0.001 per share · CUSIP: 54948X109
Event date: 2025-10-09
- Filing-level shares
- 38,816,903.00
- Percent of class
- 28.3%
- PAVmed Inc.Reported CIK 0001624326
Shares: 38,816,903.00 · Class: 28.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-017859
- Form type
- SCHEDULE 13D/A
- Filer
- Lucid Diagnostics Inc.
- CIK
- CIK 1799011
- Filed
- Oct 10, 2025
- Reporting period
- Oct 09, 2025
- Description
- Schedule 13D beneficial ownership